Clinical Trial

Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Based on the Tongren Myopia and Amblyopia Therapeutic Apparatus (a 650nm low-level red-light device) developed by the research team in the previous phase, the device was modified by replacing the light source with LED light. Subsequently, a population study was conducted to evaluate its efficacy and safety in myopia prevention and control.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-28.
Status change: Recruiting → Not Yet Recruiting 2026-02-06
Trial Details
NCT Number NCT07208617
Lead Sponsor Beijing Tongren Hospital
Conditions Myopia
Enrollment 206 participants
Start Date 2026-02-12
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-10